Adaptimmune Therapeutics Revenue

Adaptimmune Therapeutics had revenue of $13.68M USD in the quarter ending June 30, 2025, a decrease of -89.33%. This brings the company's revenue in the last twelve months to $65.09M, down -53.99% year-over-year. In the year 2024, Adaptimmune Therapeutics had annual revenue of $178.03M with 195.34% growth.

Revenue (ttm)

$65.09M

Revenue Growth

-53.99%

P/S Ratio

0.02

Revenue / Employee

$128.63K

Employees

506

Market Cap

1.15M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	178.03M	117.75M	195.34%
Dec 31, 2023	60.28M	33.13M	122.05%
Dec 31, 2022	27.15M	21.00M	341.50%
Dec 31, 2021	6.15M	2.19M	55.36%
Dec 31, 2020	3.96M	2.84M	252.76%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
co.don AG	6.24M
Paion AG	14.81M
bioXXmed AG	20.49K
MagForce AG	1.08M
Biomark Diagnostics	57.01K
2invest AG	8.89M
Darwin AG	27.35M
Biotest Aktiengesellschaft	635.20M

Revenue Rankings